Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata
Clinical trial NCT04034134 · COMPLETED
Trial details
- NCT number
- NCT04034134
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-18
- Primary completion
- 2021-11-26
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.